JANUX THERAPEUTICS INC (JANX)
US47103J1051 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 7.80M | |||
| Cash Equivalents | 26.75M | 19.20M | 51.40M | 35.60M | N/A | |||
| Marketable Securities | 631.28M | 324.82M | 275.60M | 339.40M | N/A | |||
| Receivables | N/A | N/A | N/A | 0.00 | 8.00M | |||
| Other Current Assets | 8.29M | 5.21M | 5.40M | 2.10M | 200.00K | |||
| Total Current Assets | 666.32M | 349.24M | 332.40M | 377.00M | 16.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 25.06M | 27.84M | 29.40M | 1.60M | 200.00K | |||
| Other Non-Current Assets | 3.64M | 3.33M | 2.20M | 1.20M | 0.00 | |||
| Total Non-Current Assets | 28.70M | 31.17M | 31.60M | 2.80M | 100.00K | |||
| TOTAL ASSETS | 695.02M | 380.41M | 364.00M | 379.80M | 16.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 14.71M | 8.88M | 8.80M | 4.00M | 800.00K | |||
| Accounts Payable | 2.46M | 2.42M | 2.20M | 2.50M | 400.00K | |||
| Other Current Liabilities | 0.00 | 1.73M | 5.60M | 6.40M | 2.00M | |||
| Total Current Liabilities | 17.17M | 13.03M | 16.50M | 12.80M | 3.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 21.74M | 23.02M | 26.80M | 700.00K | 6.10M | |||
| Total Non-Current Liabilities | 21.74M | 23.02M | 26.80M | 700.00K | 6.00M | |||
| TOTAL LIABILITIES | 38.91M | 36.06M | 43.30M | 13.50M | 9.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -217.54M | -168.76M | -110.50M | -47.40M | -14.70M | |||
| Additional Paid In Capital | 865.76M | 512.40M | 432.70M | 414.00M | 100.00K | |||
| Common Shares | 52.00K | 46.00K | 0.00 | 0.00 | 21.60M | |||
| Other Shareholders' Equity | 7.83M | 665.00K | -1.50M | -300.00K | N/A | |||
| Shares Outstanding | 52.34M | 46.25M | 41.60M | 41.60M | 39.90M | |||
| Tangible Book Value per Share | 12.54 | 7.44 | 7.71 | 8.81 | -0.37 | |||
| Total Shareholders' Equity | 656.10M | 344.35M | 320.70M | 366.30M | 7.00M | |||
| TOTAL LIABILITIES AND EQUITY | 695.02M | 380.41M | 364.00M | 379.80M | 16.20M | |||
| Statistics | ||||||||
| Current Ratio | 38.80 | 26.80 | 20.15 | 29.45 | 5.03 | |||
| Return On Assets (ROA) | -8.71% | -15.32% | -17.32% | -8.60% | -41.85% | |||
| Return On Equity (ROE) | -9.23% | -16.93% | -19.66% | -8.92% | -96.86% | |||
All data in USD , ROIC based on taxRate of 0.21